Smith & Nephew (SNN) Interest & Investment Income (2016 - 2024)
Smith & Nephew (SNN) posted quarterly Interest & Investment Income of $9.0 million for Q4 2024, up 126.47% year-on-year from $4.0 million in Q1 2024, and up 126.47% on a QoQ basis from -$34.0 million in Q4 2023.
Smith & Nephew (SNN) Interest & Investment Income (2016 - 2024) Analysis & Trends
Smith & Nephew (SNN) has reported Interest & Investment Income for 9 consecutive years, with $9.0 million the latest figure, recorded in Q4 2024.
- Quarterly Interest & Investment Income rose 126.47% year-over-year to $9.0 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$19.0 million (up 24.0% YoY) and the FY2025 annual result came in at $28.0 million, up 16.67% from the prior year.
- Interest & Investment Income improved to $9.0 million in Q4 2024 per SNN's latest filing, from -$34.0 million in the prior quarter.
- Over the last five years, Interest & Investment Income for SNN reached as high as $9.0 million in Q4 2024 and fell as low as -$34.0 million in Q4 2023.
- A 5-year average of -$3.2 million and a median of $3.0 million in 2020 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2023 — Interest & Investment Income tumbled 1233.33% — and 2024, when it surged 126.47%.
- Year by year, Interest & Investment Income stood at $3.0 million in 2020, then changed by 0.0% to $3.0 million in 2021, then changed by 0.0% to $3.0 million in 2022, then slumped by 1233.33% to -$34.0 million in 2023, then jumped by 126.47% to $9.0 million in 2024.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $9.0 million, -$34.0 million, and $3.0 million for Q4 2024, Q4 2023, and Q4 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 33.50 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 40.98 Mn |
| 10 | Steris | 21.47 Bn | 21.03 Bn | 697.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 9.00 Mn |
| Dec 31, 2023 | -34.00 Mn |
| Dec 31, 2022 | 3.00 Mn |
| Dec 31, 2021 | 3.00 Mn |
| Dec 31, 2020 | 3.00 Mn |
| Dec 31, 2019 | 5.00 Mn |
| Dec 31, 2018 | 4.00 Mn |
| Dec 31, 2017 | 3.00 Mn |
| Dec 31, 2016 | 2.00 Mn |